180
Participants
Start Date
January 13, 2020
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 212929, Athens
Henry Dunnant Hospital Center /ID# 241682, Athens
General Hospital of Athens Gennimatas /ID# 212917, Athens
General Hospital of Athens Laiko /ID# 212902, Athens
General Hospital of Athens Laiko /ID# 230222, Athens
University General Hospital Attikon /ID# 212915, Athens
Iatriko Kentro Athinon /ID# 241689, Marousi
Iatriko Kentro Athinon /ID# 241690, Marousi
Metropolitan General /ID# 212934, Cholargós
Metropolitan Hospital /ID# 241687, Piraeus
METAXA Cancer Hospital of Piraeus /ID# 212918, Piraeus
General Hospital of Patras Agios Andreas /ID# 213711, Pátrai
University Gen Hosp of Patra /ID# 212914, Pátrai
Reg Gen Univ Hosp Larissa /ID# 213708, Larissa
University General Hospital of Ioannina /ID# 212936, Ioannina
Theageneio Anticancer Hospital /ID# 212933, Thessaloniki
Papageorgiou General Hospital /ID# 213710, Thessaloniki
General Hospital of Thessaloniki George Papanikolaou /ID# 213709, Thessaloniki
General University Hospital of Alexandroupolis /ID# 212927, Alexandroupoli
University General Hospital of Heraklion PA.G.N.I /ID# 212916, Heraklion
"General Hospital of Chania Agios Georgios /ID# 241685", Chania
Lead Sponsor
AbbVie
INDUSTRY